Introduction: We examined the relationship between previous fluctuations in Mini-Mental State Examination (MMSE) scores, future changes in MMSE scores, and attrition from follow-up surveys, which helps in a more comprehensive interpretation of repeatedly collected MMSE scores. Methods: This 4-year longitudinal study included 2,073 community-dwelling older adults aged ≥65 years in Japan. The MMSE was administered at baseline (T0), 2 years (T1), and 4 years (T2) follow-up. We performed multinomial logistic regression analysis with the dependent variable, indicating the change in MMSE score from T1 to T2 (categorized as increase, no change [reference category], and decrease) and attrition at T2. The independent variables included the change in MMSE scores from T0 to T1 and MMSE scores at T0 and T1. Results: The mean MMSE score was 29 across the three time points. A one-point decrease in MMSE score from T0 to T1 was associated with 79% (95% confidence interval: 1.62, 1.97) higher odds of an increase in MMSE score from T1 to T2 and 28% (1.17, 1.40) higher odds of attrition at T2. A one-point decrement in the MMSE score at T0 and T1 was also associated with an increase in the MMSE score from T1 to T2 and attrition at T2. Conclusion: Focusing on cognitive fluctuation for 2 years, rather than cognitive function at a point in time, would have no remarkable advantage when focusing on future cognitive function and attrition. Our results emphasize the need for further studies to identify factors that distinguish between those who continue to attend follow-up surveys and show improvements in cognitive test scores and those who drop out.

Journal Section:
Research Article
Keywords:
Attrition, Cognitive fluctuation, Cognitive function, Community setting, Drop out, Mini-Mental State Examination
1.
Canevelli M, Grande G, Lacorte E, Quarchioni E, Cesari M, Mariani C, et al. Spontaneous reversion of mild cognitive impairment to normal cognition: a systematic review of literature and meta-analysis. J Am Med Dir Assoc. 2016;17(10):943–8.
https://doi.org/10.1016/j.jamda.2016.06.020
2.
Malek-Ahmadi M. Reversion from mild cognitive impairment to normal cognition: a meta-analysis. Alzheimer Dis Assoc Disord. 2016;30(4):324–30.
https://doi.org/10.1097/WAD.0000000000000145
3.
Ganguli M, Jia Y, Hughes TF, Snitz BE, Chang CCH, Berman SB, et al. Mild cognitive impairment that does not progress to dementia: a population-based study. J Am Geriatr Soc. 2019;67(2):232–8.
https://doi.org/10.1111/jgs.15642
4.
Overton M, Pihlsgård M, Elmståhl S. Diagnostic stability of mild cognitive impairment, and predictors of reversion to normal cognitive functioning. Dement Geriatr Cogn Disord. 2019;48(5–6):317–29.
https://doi.org/10.1159/000506255
5.
Angevaare MJ, Vonk JMJ, Bertola L, Zahodne L, Watson CWM, Boehme A, et al. Predictors of incident mild cognitive impairment and its course in a diverse community-based population. Neurology. 2022;98(1):e15–26.
https://doi.org/10.1212/WNL.0000000000013017
6.
Aerts L, Heffernan M, Kochan NA, Crawford JD, Draper B, Trollor JN, et al. Effects of MCI subtype and reversion on progression to dementia in a community sample. Neurology. 2017;88(23):2225–32.
https://doi.org/10.1212/WNL.0000000000004015
7.
Lipnicki DM, Crawford J, Kochan NA, Trollor JN, Draper B, Reppermund S, et al. Risk factors for mild cognitive impairment, dementia and mortality: the Sydney memory and ageing study. J Am Med Dir Assoc. 2017;18(5):388–95.
https://doi.org/10.1016/j.jamda.2016.10.014
8.
Xue HP, Hou P, Li YN, Mao X, Wu LF, Liu YB. Factors for predicting reversion from mild cognitive impairment to normal cognition: a meta-analysis. Int J Geriatr Psychiatry. 2019;34(10):1361–8.
https://doi.org/10.1002/gps.5159
9.
Chatfield MD, Brayne CE, Matthews FE. A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies. J Clin Epidemiol. 2005;58(1):13–9.
https://doi.org/10.1016/j.jclinepi.2004.05.006
10.
Chang CCH, Yang HC, Tang G, Ganguli M. Minimizing attrition bias: a longitudinal study of depressive symptoms in an elderly cohort. Int Psychogeriatr. 2009;21(5):869–78.
https://doi.org/10.1017/S104161020900876X
11.
Maharani A, Dawes P, Nazroo J, Tampubolon G, Pendleton N; Sense-Cog WP1 group. Visual and hearing impairments are associated with cognitive decline in older people. Age Ageing. 2018;47(4):575–81.
https://doi.org/10.1093/ageing/afy061
12.
Griswold ME, Talluri R, Zhu X, Su D, Tingle J, Gottesman RF, et al. Reflection on modern methods: shared-parameter models for longitudinal studies with missing data. Int J Epidemiol. 2021;50(4):1384–93.
https://doi.org/10.1093/ije/dyab086
13.
Vega S, Benito-León J, Bermejo-Pareja F, Medrano MJ, Vega-Valderrama LM, Rodríguez C, et al. Several factors influenced attrition in a population-based elderly cohort: neurological disorders in Central Spain Study. J Clin Epidemiol. 2010;63(2):215–22.
https://doi.org/10.1016/j.jclinepi.2009.03.005
14.
Abe T, Kitamura A, Yamashita M, Kim H, Obuchi SP, Ishizaki T, et al. Simple screening models for cognitive impairment in community settings: the IRIDE Cohort Study. Geriatr Gerontol Int. 2022;22(4):292–7.
https://doi.org/10.1111/ggi.14360
15.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–98.
https://doi.org/10.1016/0022-3956(75)90026-6
16.
Koyano W, Shibata H, Nakazato K, Haga H, Suyama Y. Measurement of competence: reliability and validity of the TMIG index of competence. Arch Gerontol Geriatr. 1991;13(2):103–16.
https://doi.org/10.1016/0167-4943(91)90053-s
17.
Satake S, Arai H. The revised Japanese version of the Cardiovascular Health Study criteria (revised J-CHS criteria). Geriatr Gerontol Int. 2020;20(10):992–3.
https://doi.org/10.1111/ggi.14005
18.
Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–7.e2.
https://doi.org/10.1016/j.jamda.2019.12.012
19.
Kaufer DI, Williams CS, Braaten AJ, Gill K, Zimmerman S, Sloane PD. Cognitive screening for dementia and mild cognitive impairment in assisted living: comparison of 3 tests. J Am Med Dir Assoc. 2008;9(8):586–93.
https://doi.org/10.1016/j.jamda.2008.05.006
20.
Hensel A, Angermeyer MC, Riedel-Heller SG. Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination. J Neurol Neurosurg Psychiatry. 2007;78(12):1298–303.
https://doi.org/10.1136/jnnp.2006.109074
21.
Tombaugh TN. Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS. Arch Clin Neuropsychol. 2005;20(4):485–503.
https://doi.org/10.1016/j.acn.2004.11.004
22.
Young AF, Powers JR, Bell SL. Attrition in longitudinal studies: who do you lose?Aust N Z J Public Health. 2006;30(4):353–61.
https://doi.org/10.1111/j.1467-842x.2006.tb00849.x
23.
Kawai H, Ejiri M, Tsuruta H, Masui Y, Watanabe Y, Hirano H, et al. Factors associated with follow-up difficulty in longitudinal studies involving communitydwelling older adults. PLoS One. 2020;15(8):e0237166.
https://doi.org/10.1371/journal.pone.0237166
24.
Fielding S, Fayers PM, Loge JH, Jordhøy MS, Kaasa S. Methods for handling missing data in palliative care research. Palliat Med. 2006;20(8):791–8.
https://doi.org/10.1177/0269216306072555
25.
Jacobsen E, Ran X, Liu A, Chang CCH, Ganguli M. Predictors of attrition in a longitudinal population-based study of aging. Int Psychogeriatr. 2021;33(8):767–78.
https://doi.org/10.1017/S1041610220000447
© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.